Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial
Vahideh Behrouz, Naheed Aryaeian, Mohammad Javad Zahedi, et al.
Journal of Food Science (2020) Vol. 85, Iss. 10, pp. 3611-3617
Closed Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

The gut–liver axis and gut microbiota in health and liver disease
Cynthia L. Hsu, Bernd Schnabl
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 719-733
Closed Access | Times Cited: 206
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
Jie Fang, Chen-Huan Yu, Xuejian Li, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 95
The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
Rodrigo Zamignan Carpi, Sandra Maria Barbalho, Kátia Portero Sloan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8805-8805
Open Access | Times Cited: 87
The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 640-640
Open Access | Times Cited: 41
The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Yijia Song, Sutong Liu, Lihui Zhang, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 1
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
Ji Won Park, Sung Eun Kim, Na Young Lee, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 426-426
Open Access | Times Cited: 70
The future of functional food: Emerging technologies application on prebiotics, probiotics and postbiotics
Celso F. Balthazar, Jonas F. Guimarães, Nathália M. Coutinho, et al.
Comprehensive Reviews in Food Science and Food Safety (2022) Vol. 21, Iss. 3, pp. 2560-2586
Closed Access | Times Cited: 63
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Elke Roeb, Ali Canbay, Frank Tacke, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. 1346-1421
Open Access | Times Cited: 51
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 27
Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Xiangyu Zhou, Jincheng Wang, Sufang Zhou, et al.
Medicine (2023) Vol. 102, Iss. 4, pp. e32734-e32734
Open Access | Times Cited: 25
Role of intestinal probiotics in the modulation of lipid metabolism: implications for therapeutic treatments
Xiaoran Song, Yanan Liu, Xin Zhang, et al.
Food Science and Human Wellness (2023) Vol. 12, Iss. 5, pp. 1439-1449
Open Access | Times Cited: 24
Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
Roman Maslennikov, Elena Poluektova, O. Yu. Zolnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16502-16502
Open Access | Times Cited: 24
What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Marcin Kosmalski, Rafał Frankowski, Sylwia Ziółkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1852-1852
Open Access | Times Cited: 22
Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
Youwen Pan, Yafang Yang, Jiale Wu, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis
Yuezhi Zhu, Jen Kit Tan, Jia Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 329-329
Open Access | Times Cited: 8
Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice
Gabriela V. Moreira, Layanne C. C. Araujo, Gilson Masahiro Murata, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113660-113660
Open Access | Times Cited: 27
Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study
Amirhossein Naghipour, Ehsan Amini‐Salehi, Mahdi Orang Gorabzarmakhi, et al.
Systematic Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
María Del Barrio, Lucía Lavín-Alconero, Álvaro Santos‐Laso, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6123-6123
Open Access | Times Cited: 17
Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
Alejandra Mijangos-Trejo, Natalia Nuño‐Lámbarri, Varenka J. Barbero-Becerra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14918-14918
Open Access | Times Cited: 17
Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvement
You-Tae Kim, David A. Mills
Food Science and Biotechnology (2024) Vol. 33, Iss. 9, pp. 2065-2080
Closed Access | Times Cited: 6
Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
Qingyi Mao, Beibei Lin, Wenluo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial
Amanda Souza Silva-Sperb, Helena Abadie Moraes, Samantha Thifani Alrutz Barcelos, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 5
Various Prebiotics and Probiotics, Their Usage and Importance in Maintaining Normal Microflora in Animal
Muhammad Talha Ahmad, Dost Muhammad Khan, Sidra Khan, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 245-254
Closed Access
Deciphering the role of Dietary Modifications and Gut Dysbiosis in Non-Alcoholic Fatty Liver Disease
Meenakshi Vachher, Kamaljeet Kaur, Manisha Mahrotra, et al.
Human Nutrition & Metabolism (2025), pp. 200305-200305
Open Access
Association of the use of nonfood prebiotics, probiotics, and synbiotics with total and cause-specific mortality: a prospective cohort study
Luyan Zheng, Jiaqi Zhang, Jing Yang, et al.
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top